All posts by imreal

Labor Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, File Suit Against Alto Pharmacy LLC, for Allegedly Failing to Reimburse Employees for Cell Phone Usage


Law Office of Blumenthal Nordrehaug Bhowmik De Blouw LLP

For more information about the class action lawsuit against Alto Pharmacy LLC, call (800) 568-8020 to speak to an experienced California employment attorney today.

The San Francisco employment law attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, filed a class action lawsuit against Alto Pharmacy LLC alleging the company violated the California Labor Code. The lawsuit against Alto Pharmacy LLC is currently pending in the San Francisco County Superior Court, Case No. CGGC-22-601836. To read a copy of the Complaint, please click here.

According to the lawsuit filed, Alto Pharmacy LLC allegedly (a) failed to pay minimum wages, (b) failed to pay overtime wages, (c) failed to provide legally required meal and rest periods, (d) failed to provide accurate itemized wage statements, (e) failed to reimburse employees for required expenses, and (f) failed to pay sick pay wages, all in violation of the applicable Labor Code sections listed in California Labor Code Sections §§ 201-204, 226, 226.7, 233, 246, 510, 512, 1194, 1197, 1197.1, 2802, and the applicable Wage Order(s), and thereby gives rise to civil penalties as a result of such alleged conduct.

Alto Pharmacy LLC allegedly failed to reimburse employees for required business expenses. California Labor Code §2802 expressly states that “an employer shall indemnify his or her employee for all necessary expenditures or losses incurred by the employee in direct consequence of the discharge of his or her duties…” During employment, Plaintiff and other California Class Members were allegedly required to use their personal cellular phones as a result of and in furtherance of their job duties.

For more information about the class action lawsuit against Alto Pharmacy LLC, call (800) 568-8020 to speak to an experienced California employment attorney today.

Blumenthal Nordrehaug Bhowmik De Blouw LLP is a labor law firm with law offices located in San Diego County, Riverside County, Los Angeles County, Sacramento County, Santa Clara County, Orange County and San Francisco County. The firm has a statewide practice of representing employees on a contingency basis for violations involving unpaid wages, overtime pay, discrimination, harassment, wrongful termination and other types of illegal workplace conduct.

***THIS IS AN ATTORNEY ADVERTISEMENT***

Share article on social media or email:

The Bone Heath and Osteoporosis Foundation is Named an Official Charity Partner of the 2022 TCS New York City Marathon


The Bone Health and Osteoporosis Foundation (BHOF) was named an Official Charity Partner for the 2022 TCS New York City Marathon, taking place on November 6, 2022. BHOF will be among the 500 official charity partners providing thousands of runners the opportunity to run in the world’s most popular marathon.

In the U.S., more than 2 million broken bones are caused by osteoporosis annually. Studies show that half of all women over the age of 50 (and 1 in 4 men) will break a bone due to osteoporosis in their lifetime. BHOF’s Be Bone Strong™ team will work to raise much-needed funds to help BHOF improve patient care, support those who have broken bones due to osteoporosis and educate the public about this chronic but preventable disease.

The Be Bone Strong™ team includes 12 runners. Barbara Hannah Grufferman, 65, is team captain. She is a BHOF Trustee, a nationally recognized advocate for positive living, award-winning author, and an avid marathoner. She will provide guidance and support for the team throughout their training. To date, Barbara has run 14 marathons, countless half-marathons, and other smaller races, all since turning 50. To learn more about Barbara and the rest of the team members visit https://www.bonehealthandosteoporosis.org/about-us/building-awareness/tcs-new-york-city-marathon-2022.

“The TCS New York City Marathon serves as one of the world’s largest fundraising platforms supporting hundreds of charities and philanthropic efforts,” said Christine Burke, Senior VP of Strategic Partnerships, NYRR. “We are very proud to support the Bone Health and Osteoporosis Foundation team and the incredible impact they have made to their communities as they raise important funds to benefit to promote strong bones for life”

The NYRR Official Charity Partner Program offers an opportunity for nonprofit organizations to raise funds to support their missions and services. Participating charities can offer guaranteed entry to runners who fundraise on their behalf.

Since its inception in 2006, the TCS New York City Marathon Official Charity Partner Program has raised more than $400 million for more than 1,000 worthy nonprofit organizations across the globe. Prior to the start of the official program, the New York City Marathon had served as an outlet for individual philanthropic runners since the 1980s.

###

About the Bone Health and Osteoporosis Foundation (formerly the National Osteoporosis Foundation)

Established in 1984, the Bone Health and Osteoporosis Foundation is the nation’s leading health organization dedicated to promoting strong bones for life, preventing osteoporosis and broken bones, and reducing human suffering through programs of awareness, education, advocacy, and research. For more information on the Bone Health and Osteoporosis Foundation, visit http://www.bonehealthandosteoporosis.org

About New York Road Runners (NYRR)

NYRR’s mission is to help and inspire people through running. Since 1958, New York Road Runners has grown from a local running club to the world’s premier community running organization. NYRR’s commitment to New York City’s five boroughs features races, virtual races, community events, free youth running initiatives and school programs, the NYRR RUNCENTER featuring the New Balance Run Hub, and training resources that provide hundreds of thousands of people each year with the motivation, know-how, and opportunity to Run for Life. NYRR’s premier event, and the largest marathon in the world, is the TCS New York City Marathon. Held annually on the first Sunday in November, the race features a wide population of runners, from the world’s top professional athletes to a vast range of competitive, recreational, and charity runners. To learn more, visit http://www.nyrr.org.

Share article on social media or email:

Mindray To Debut New Perioperative Solutions At ANESTHESIOLOGY 2022


Mindray North America Perioperative Solutions

Mindray North America Perioperative Solutions

Mindray is debuting for the first time together at the ANESTHESIOLOGY 2022 their newest point of care ultrasound (POCUS), the TE X Ultrasound Machine, their new A8 & A9 Anesthesia Workstations, and their innovative BeneVision N-Series Patient Monitors at Booth 2847.

Mindray North America, a global leader and developer of healthcare technologies and solutions for ultrasound, anesthesia, and patient monitoring, announced today that they are attending the American Society of Anesthesiologists (ASA) ANESTHESIOLOGY Annual Meeting in New Orleans, LA, October 22-24. Mindray is debuting for the first time together at the ANESTHESIOLOGY Annual Meeting their newest point of care ultrasound (POCUS), the TE X Ultrasound Machine, their new A8 & A9 Anesthesia Workstations, and their innovative BeneVision N-Series Patient Monitors. These three product lines push the boundaries of what is possible in anesthesia, ultrasound, and patient monitoring to bring innovation to the perioperative environment.

“Based on an insightful look into the perioperative market needs, we realize solutions that build upon existing technologies and workflows are needed to elevate OR clinicians and better support their day-to-day,” said Melanie Rosen, Sr. Marketing Manager, Perioperative Solutions. Rosen continued, “We are excited to unveil our new, complete perioperative solution at ANESTHESIOLOGY Annual Meeting this year. We invite all attendees to stop by Booth 2847 and witness how we advance medical technologies to make healthcare more accessible.”

Mindray’s perioperative solutions on display throughout this year’s ANESTHESIOLOGY Annual Meeting exhibit include:


  • TE X Ultrasound System: Powered by Mindray’s proprietary Zone Sonography Technology+ (ZST+), the newly released tablet-based ultrasound system provides access to advanced diagnostic data, the ability to adapt to various clinical scenarios at the point of care, and best-in-class imaging to help clinicians provide a higher standard of care.
  • A8 and A9 Anesthesia Workstations: Mindray’s newest A8 and A9 anesthesia platform elevates traditional anesthesia by retaining conventional features while introducing innovative technology that complements how clinicians work best.
  • BeneVision N-Series Patient Monitors: Offering a full suite of monitors, the N-Series delivers a comprehensive, modular platform with user-configurable settings and a platform-wide UI with smartphone-like usability to complement clinical workflow.

With over 30 years of experience, Mindray has deep-seated roots and a sole focus on the healthcare industry. Since its founding, Mindray has been dedicated to developing innovative and accessible solutions. The TE X Ultrasound Machine, the A8 and A9 Anesthesia Workstations, and N-Series Patient Monitors continue this legacy of disruptive technology and apply meaningful innovation to drive impactful results, complementing clinical workflow and enhancing patient care in the operating room.

About Mindray

Mindray is a leading developer, manufacturer, and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools across three primary business segments: medical imaging, patient monitoring and life support, and in-vitro diagnostics. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in San Jose, California, with additional facilities in major international markets around the world. For more information, please visit http://www.mindray.com.

Share article on social media or email:

Voxela announced that Living Platform, a leading Japanese Nursing Home and Assisted Living Home provider, has invested in Voxela


Voxela, Inc.

Voxela, Inc.

“We believe that our investment in Voxela, which is developing AI technology aimed at identifying and preventing the signs of falls, will contribute to our goal of a society that fosters peace of mind and solves challenges through technology.” (Hirofumi Kaneko, CEO, Living Platform, Ltd.)

Voxela was founded in Silicon Valley as a company that uses Vision AI to create a comprehensive, personalized database of movements and physical activities. The company has already developed solutions to detect and prevent falls and wandering incidents.

Voxela’s mission is to offer excellent care through technology by reinventing what a nursing home should be and leveraging technology to enable affordable care. Voxela’s technology addresses the longstanding challenges of eldercare in Japan and globally.

Voxela VCare is an AI care management service that can perform everything from assessment, monitoring of daily conditions, accident detection, notification, and evaluation. It maintains utmost privacy, collecting only necessary information from cameras already installed for monitoring the facility. Voxela VCare enables real-time and medium- to long-term personalized prognosis using data accumulated through daily use.

Living Platform, which operates a nationwide care business with a core focus on nursing homes, childcare, and support for the disabilities, announced that it has invested in Voxela to support the development of its technology.

“Accidents such as falls among elderly residents of nursing homes carry a high risk of serious illness and have a significant impact on their subsequent health and quality of life. We believe that our investment in Voxela, which is developing AI technology aimed at identifying and preventing the signs of falls, will contribute to our goal of a society that fosters peace of mind and solves challenges through technology.” (Hirofumi Kaneko, CEO, Living Platform, Ltd.)

With the support of Living Platform, Voxela will continue to focus on research and development of AI-based care management that can lay the foundation for eldercare and provide more efficient and effective care while leveraging the knowledge gained from the aging population in Japan.

Please refer to Voxela’s Seed Round Press Release from here.

About Living Platform, Ltd.

Living Platform, Ltd. was established in 2011 with the vision of “Building a sustainable social security system.” Living Platform, Ltd. owns 62 elderly care facilities, 21 support facilities for people with disabilities, and 14 childcare facilities throughout Japan, providing comprehensive services (as of August 31, 2022), and was listed on the Tokyo Stock Exchange Mothers (now Growth Market) in March 2020. https://living-platform.com

About Voxela Inc.

Voxela, Inc. is a Silicon Valley-based technology company with a mission to reinvent eldercare services by developing next-generation care management solutions using Vision AI technology. Founded in 2021 by serial entrepreneurs Yuta Endo, Goutham Kamath, and Yusuke Yoshida, Voxela VCare, a next-generation eldercare solution service, is being introduced at Nursing Home/Assisted Living facilities across Japan, and the company aims to expand to other countries. https://www.voxela.ai

For any inquiries about Voxela, Inc. and its product “Voxela VCare,” please contact info@voxela.ai

Share article on social media or email:

Heartbeat Group Creative Director Chris Whaites Honored as Agency Vanguard Award Winner by Xpectives.Health


I’ve seen firsthand the profound impact that healthcare advertising can have on people’s lives; it’s why I’ll always be grateful to be a part of this industry.

Chris Whaites, Group Creative Director for leading healthcare marketing agency Heartbeat, has been recognized by Xpectives.Health as one of its annual Agency Vanguard Award winners.

Xpectives.Health is one of the leading forums for direct-to-consumer (DTC) advertising thought leaders. The Agency Vanguard Award recognizes standout agency team members who are driving innovation and improving patient communications. It is awarded to select agency executives for their extensive accomplishments, influence on future consumer health launches or campaigns, and contributions and service to patients and the overall DTC industry.

Whaites received this honor following nearly three decades in the marketing industry, with 24 of those years devoted exclusively to healthcare advertising. He joined Heartbeat in 2003 as one of the agency’s earliest Creative hires and is fast approaching his 20th anniversary with the company.

Along with his immense talent and relentless dedication, he is known for bringing insight, empathy, and a passion for powerful yet simple storytelling to his work. His extensive list of industry experience includes some of the most recognizable brands in healthcare, such as Tylenol®, Cimzia®, Xyzal®, Viagra®, and Cialis®. More recently, Whaites played a key role in the launch of a blockbuster immuno-oncology therapy, as well as the creative efforts behind an unbranded atrial fibrillation and deep vein thrombosis/pulmonary embolism awareness campaign — where his work earned him seven major industry honors.

“I’ve seen firsthand the profound impact that healthcare advertising can have on people’s lives; it’s why I’ll always be grateful to be a part of this industry,” Whaites noted. “And I’m equally grateful to be part of an agency that has allowed me to grow into the Creative I am today. To be mentored by the likes of Bill Drummy and James Talerico makes me one lucky Creative. I’m looking forward to the road ahead.”

Whaites is the fourth Heartbeat executive to receive Agency Vanguard recognition. The agency’s Executive Vice President of Marketing Janelle Starr received the distinction in 2019, following Heartbeat Senior Vice President of Strategy Hudson Plumb in 2018 and President/Executive Creative Director, James Talerico, in 2017.

Whaites and the other Agency Vanguard Award recipients will be honored at a ceremonial dinner on October 13, 2022, at the W Hotel in Hoboken, New Jersey.

About Heartbeat

Heartbeat is a full-service agency for healthcare Challenger Brands. Challengers are playing a high-stakes game—they must battle behemoth market leaders, upend ingrained treatment habits, or transform a “me-too” product into “yes-please.”

The agency is known for serving up distinctive strategies and differentiating approaches, ensuring clients’ market positions are uniquely owned. Heartbeat designs its organization around a “100% Integration” model, housing media, strategy, med comms, creative, technology, and even point of care/population health under the same roof for the tightest, most integrated campaigns possible. It prices work based on outcomes, not outputs. Its innovative model delivers not only alignment but also powerful orchestration, greater efficiency, and maximum impact for every dollar spent—all the necessary elements for Challengers to triumph.

That’s the philosophy, here’s the creds: nearly 300 employees between NYC & LA; multiple agency leaders with decades of tenure; a pile of awards from the likes of the MANNYs, MM+M Awards, OMMAs, and Clios; an industry-leading commitment to diversity & inclusion (with a Med Ad News D&I Champion nod to match); and a President who dared to be quoted as follows, “We celebrate people who stand up and say, ‘You know what? This is dumb.’” Damn straight.

For more information about Heartbeat, please email marketing@weareheartbeat.com.

Share article on social media or email:

MDsave saves patients over $130M over 400k Transactions


MDsave, the nation’s leading online purchasing platform for healthcare procedures, announced today they have saved patients over $130M across 400k transactions since its inception in 2011. MDsave knows it is critical to offer patients affordable options for necessary healthcare services especially for those who are underinsured, uninsured, or who have trouble paying out of pocket healthcare costs with high deductible health plans. They continue to find solutions and partnerships that make healthcare more affordable without compromising quality.

“We have achieved some incredible milestones over the last decade and we want to celebrate those accomplishments with our partners,” says Paul Ketchel, co-founder and chief executive officer, MDsave.

Key Milestones:

  • Over the past 11 years, MDsave has helped patients save over $130M across 400k transactions in healthcare procedures.
  • MDsave was recently named in the 2022 KLAS Emerging Solutions Top 20 Repor t, earning a #4 ranking in improving patient experience.
  • Grown to a network of 320 hospitals, 1,700 physical locations, 3,000+ providers and 2,000+ shoppable procedures.
  • Onboarding an additional 2,500+ provider locations by Q1 2023 as MDsave continues to build out its direct to employer strategy.
  • MDsave’s transparent pricing bundles saves consumers an average of $600 on their care.


“While we celebrate our past, we also look forward to bringing this level of quality care combined with cost transparency to more patients. Bundled healthcare services are a win for patients, providers and employers,” concludes Paul Ketchel.

About MDsave

Headquartered in Nashville, TN, MDsave is the nation’s leading online purchasing platform for healthcare services — bringing together patients seeking affordable, reliable care with providers offering high-quality services at fair prices. Through innovative technology, MDsave simplifies the healthcare billing process for patients and providers alike through transparent bundled pricing and upfront payment. MDsave’s patented technology also supports employers and payers to deliver more value to employees and policyholders minimizing out-of-pocket deductible costs. For more information, visit http://www.mdsave.com.

Share article on social media or email:

entry-level 80% TKL QMK customizable mechanical keyboard


News Image

“Our V-series is all about accessibility,” said Paul Tan, COO of Keychron. “We’re creating entry-level keyboards in the best layouts to encourage people to switch over to the amazing world of custom keyboards.”

Today Keychron, established manufacturer of wireless mechanical keyboards for Mac, Windows and Android, launched direct sales of V3, a customizable tenkeyless (TKL) quantum mechanical keyboard (QMK). This customizable model has a classic 80% layout with many premium features like QMK/VIA support, PBT keycaps, screw-in stabilizers and more, which provides endless possibilities and a comfortable typing experience. Two styles—frosted black (translucent) and carbon black (non-transparent) are available. It comes fully assembled for $84 USD, fully assembled with knob for $94 USD, barebone for $64 USD, and barebone with knob for $74 USD.

“Our V-series is all about accessibility,” said Paul Tan, COO of Keychron. “We’re creating entry-level keyboards in the best layouts to encourage people to switch over to the amazing world of custom keyboards. TKL layout is a classic style that’s very familiar to gamers and programmers who have deeply ingrained habits. It forgoes the number pad, allowing for wider mouse movement and quick access to the required keys. It felt essential that we add this layout to our V-series.”

Like its predecessors (V1 and V2), V3 offers massive improvements in typing experience, as compared to regular keyboards. This model is supported by QMK/VIA software, which offers users endless possibilities of customization and meets their needs in different situations. It features double-shot PBT keycaps, an acoustic silicone pad, and other premium features like south-facing RGB, tray mount design, hot swappable switches, and 1000 Hz polling rate. Customization is supercharged with one of Keychron’s most popular features—a programmable knob. Designed to enhance creative workflows, the knob allows users to easily customize their favorite keys and macros, such as zooming in/out, adjusting screen brightness, brush size, volume or selecting video clips of photos.

Inside the keyboard is an epic core. A powerful ultra-low-power ARM architecture MCU equipped with 128K Flash provides more flexibility for developers. The polling rate is 1000 Hz out of the box, which makes latency non-existent for the competitive game.

Keychron’s double-shot PBT keycaps have a similar height to the OEM profile and have an SA-like shape. They named it the OSA (OEM spherical angled) keycap. The PBT keycaps provide excellent oil resistance, enhance the type feel, and prevent the legends from fading out.

This customizable keyboard offers a unique Mac layout that retains the same multimedia and function keys as the Apple keyboard, while still being compatible with Windows devices. It comes with a system toggle and an additional set of customized keycaps for both Windows and macOS systems, allowing users to save two different layouts on the keyboard.

The fully assembled version includes: ABS plastic housing, the keyboard PCB, screw-in stabs, steel plate, double-shot OSA PBT keycaps (including Mac & Windows keycaps), and Keychron K Pro switches.

Media wishing to interview Keychron personnel should contact PR agent Borjana Slipicevic at borjana@properpropaganda.net

About Keychron

Keychron was formed in 2017 by a group of keyboard enthusiasts, designers, marketers, and production experts. The founding team members, Will Ye and Sven Zhu have a combined 20 years of experience in keyboard production and industrial design. They’ve dedicated themselves to creating the most sophisticated mechanical keyboards with minimalist design. To date, the team has successfully launched and fulfilled 25 mechanical keyboards to customers in 80 countries.

Media Contact

Borjana Slipicevic

Proper Propaganda

borjana@properpropaganda.net

Share article on social media or email:

Texere Appoints Chief Commercial Officer to Drive Continued Growth


Texere Appoints Chief Commercial Officer to Drive Continued Growth

Texere Appoints Chief Commercial Officer to Drive Continued Growth

“I am delighted to have the opportunity to play an even more senior role at Texere… In ten years, we have built several respected, established brands, with another two on the runway – and we don’t plan on stopping. It’s a brilliant time for the business.”

Texere Publishing is delighted to announce the promotion of Richard Hodson to the role of Chief Commercial Officer.

Joining Texere as a publisher in May 2014, Richard Hodson oversaw the successful global launch of Texere’s first Pharmaceutical brand, The Medicine Maker. After five successful years, Hodson went on to be appointed Commercial Director with responsibility for the commercial, customer support, and project delivery teams for all sectors of Texere’s business – Healthcare, Pharmaceutical, and Science.

Coinciding with Texere’s 10th anniversary, Hodson’s appointment as Chief Commercial Officer will expand his remit to include overall responsibility for all departments that are predominantly externally facing – namely, sales, commercial services, sales support, social media, and editorial.

Reflecting on his new appointment, Hodson said, “I am delighted to have the opportunity to play an even more senior role at Texere – and I do not take the trust and expectations placed upon me lightly! Fortunately, I work alongside a truly talented team – people who make the task ahead exciting rather than daunting. In ten years, we have built several respected, established brands, with another two on the runway – and we don’t plan on stopping. It’s a brilliant time for the business.”

Chief Executive Officer Andy Davies commented, “Richard has already proven himself a natural and capable leader – and always rises to the challenge. I have no doubt that his unwavering passion for – and commitment to – delivering the best experience to both our audiences and commercial partners will only be further multiplied in his new role as Chief Commercial Officer. And that puts Texere in a very good place indeed.”

About Texere Publishing

At Texere Publishing, we deliver compelling, behind the scenes stories that matter in the life sciences and medicine. Our unrivaled access to key opinion leaders, influencers, scientists, and doctors who are making a difference, means that our readers are connected to the pulse of their fields. Founded in 2012, we have expanded our editorial beat to the world with our presence in the US, Canada, and the UK. Visionary. Innovative. Fearless. Join us on our journey to cover the stories that matter to you.

Publishers of The Analytical Scientist, The Cannabis Scientist, The Medicine Maker, The Ophthalmologist, The Pathologist, and The Translational Scientist.

texerepublishing.com | Twitter | LinkedIn | Instagram | Facebook

Share article on social media or email:



Labroots Hosts 8th Event in its Coronavirus Virtual Event Series on October 19, 2022


Coronavirus Virtual Event Series, October 19, 2022

Labroots, the leading scientific social networking website offering premier, interactive virtual events and webinars, today announced the 8th event in its ongoing Coronavirus Virtual Event Series, since the inaugural launch in 2020. This educational forum brings together researchers from an array of disciplines, clinicians, epidemiologists, and scientists across leading medical, industry and academic institutions across the world sharing the latest breakthroughs to address prevention, treatment and management of COVID-19/SARS-CoV-2 and challenges presented.

The pre-eminent meeting continues to reach milestone attendance, offering a comprehensive agenda featuring distinguished speakers and innovators in healthcare today. The preceding (seven) virtual events will remain on demand for continuous viewing of valuable and informative content. The next set of presentations will go live on October 19th, 2022 at 5:30am PDT, on general topics covering epidemiology of COVD-19 – previous, current, and future trends, variants and how the virus changes, global preparedness, testing, research, and diagnostics, vaccines and future vaccines, and lessons learned via live-streaming video webcasts including keynote sessions (with live Q&A), industry-sponsored presentations, and on demand discussions available to watch immediately.

Kicking off the day, Dr. Adolfo Garcia-Sastre Professor, Departments of Microbiology and Medicine, Tisch Cancer Center Icahn School of Medicine at Mount Sinai will deliver a keynote talk titled, “A Newcastle Disease Virus-Based COVID-19 vaccine.” In his keynote, Dr. Scott A. Rivkees Professor of Practice and Vice Chair, Department of Health Services, Policy and Practice Brown University School of Public Health will explore the direct and indirect impact of the COVID-19 pandemic on children. The future of COVID-19: expectations and lessons will be discussed by keynote speaker Dr. Ali H. Mokdad, Chief Strategy Officer, Population Health, University of Washington; Director, Middle Eastern Initiatives Professor, Health Metrics Sciences Institute for Health Metrics and Evaluation, and Dr. Yvonne Maldonado, Senior Associate Dean for Faculty Development and Diversity, Taube Endowed Professor of Global Health and Infectious Diseases, Professor of Pediatrics and of Epidemiology and Population Health, Chief, Division of Pediatric Infectious Diseases, Stanford University School of Medicine will share the natural history, diagnosis and monitoring and lessons learned in SARS-CoV-2 and COVID-19 in her keynote presentation. Finally, Dr. Walter Koroshetz, Director of the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health will delve into advancing toward recovery from post-acute sequalae of SARS-CoV-2 Infection (PASC): the NIH RECOVER Initiative in his keynote talk.

“Despite the success of current SARS-CoV-2 vaccines to dramatically reduce the number of COVID-19 hospitalizations, improved vaccines with increased protection from break-through infections are highly desirable,” stated Dr. Adolfo Garcia-Sastre, Professor, Departments of Microbiology and Medicine, Tisch Cancer Center Icahn School of Medicine at Mount Sinai.

“Our children are our future and have been impacted in so many ways by the pandemic,” said Scott Rivkees, MD, Professor of Practice at the Brown School of Public Health. “In addition to comprehending the direct effect of COVID-19 itself on the pediatric population, it is important to also recognize the impact the pandemic has had on families, education, and the practice of pediatrics, and how this impact will last well beyond the end of the pandemic. I am grateful to the Labroots platform for providing a forum to discuss these important issues.”

“We have long known that people may suffer persistent symptom complexes after an acute infectious illness, but we have not been able to uncover its cause or devise effective treatments,” commented Dr. Walter Koroshetz, Director of the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health. “Now that COVID-19 has infected almost 100 million Americans, the post viral syndrome, now termed “Long COVID”, poses a major health and science challenge. The NIH RECOVER Initiative is built as a comprehensive research program to identify the underlying biology and test potential treatments. It’s a pleasure to discuss RECOVER on the Labroots platform.”

In addition to keynote presentations, other event highlights include a panel presentation sponsored by LGC Clinical Diagnostics titled, “COVID-19 Testing: Results and Recommendations from the Coronavirus Standards Working Group,” with Live Q&A. More informative lectures on Detection of SARS-CoV-2 Neutralizing Antibodies with GenScript’s SARS-CoV-2 Surrogate Virus Neutralization (sVNT) Test, A Phase 1 Trial of Cyclosporine for Hospitalized Patients with COVID-19, sponsored by NanoString Technologies, and a Thermo Fisher Scientific sponsored presentation on influenza: an underestimated threat, and much more you won’t want to miss!

Produced on Labroots’ robust platform while connecting across all desktop and mobile devices, the interactive environment delivers a seamless educational experience for all participants. The interactive event consists of a lobby with leaderboard and gamification, an auditorium featuring live-streaming video webcasts with live attendee chats during scheduled presentations, an exhibit hall to interact with sponsors and view their recent contributions in the field, a poster hall to explore data and engage in live chat conversations, and featuring a poster competition to give your research a competitive edge, and lastly a networking lounge to connect and collaborate with colleagues. By attending this virtual event series, there is potential to earn 1 P.A.C.E. Continuing Education credit per presentation.

To register for the event, click here. Use the hashtag #LRcoronavirus to follow the conversation and connect with other members of the global Coronavirus research community! Follow @Labroots on Twitter and @LabrootsInc on Facebook to connect with our team and stay up to date with the latest Trending News in Coronavirus research.

About Labroots

Labroots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events. Now, Labroots offers more than ever with Chati, a flexible, highly scalable event platform that allows for the creation of unique, effective, and memorable virtual events.

United Breast Cancer Foundation and Brookfield Properties collaborate on Pink Bag Events® for Breast Cancer Awareness Month


News Image

Although registration for this year’s Pink Bag Events® is closed, UBCF encourages breast cancer patients and survivors to register for next year. Contact your local Brookfield center to see how you can qualify.

UBCF and Brookfield Properties are pleased to announce a collaboration in which breast cancer patients and survivors will receive Pink Bags filled with gifts to brighten up their day. This is a group of events that involves dozens of hardworking individuals who are dedicated to providing comfort to those affected by breast cancer.

Brookfield Properties is a retail real estate company that operates over 130 shopping centers throughout the United States. Through this partnership, Brookfield Properties will provide space in 20 of their locations to conduct UBCF Pink Bag Events®. The Pink Bags are free gifts for breast cancer patients and survivors and include items such as beautiful cosmetics, fine soaps, jewelry, cozy socks, or assorted winter items. They also contain promo items such as lip balm, hand sanitizer, and brochures.

“It was a natural collaboration for us to work with UBCF to offer this resource at our centers.” said Stephanie Brager, senior vice president at Brookfield Properties. “Our shopping centers are deeply embedded in the communities where we operate. This is a responsibility and a privilege and we are proud to take part in this initiative throughout October.”

Although registration for this year’s Pink Bag Events® is closed, UBCF encourages breast cancer patients and survivors to register for next year. Contact your local Brookfield center to see how you can qualify.

Beth Reichart, UBCF’s Director of Operations shared, “This has been an inspiring and wonderful collaboration – exemplifying that when we work together, great things can be achieved.Thanks to our friends at Brookfield Properties, UBCF is reaching thousands of patients and survivors across the country through our generous Pink Bag Events®” Reichart continued, “Breast cancer is so draining – emotionally, physically and financially. Gifting patients and survivors Pink Bags loaded with high quality, comforting, and fun goodies, brings smiles to faces and joy to hearts. Sometimes it’s the little things that make a big difference – UBCF is here to help.”

UBCF provides financial support to breast cancer patients, survivors, and their families through eight programs . UBCF programs include breast screenings, breast reconstruction, covid grants, the Audrey B. Mastroianni college scholarship, individual grants, holistic care, and child sponsorship. Additionally, UBCF’s Network of Giving program provides those in need with tangible and useful, high quality gifts such as mattresses, personal care products and clothing. For more information on our programs, please visit https://www.ubcf.org/programs/.

One of UBCF’s clients, Kathleen, recently received an individual grant. UBCF helped her with her rent, an electric bill and an insurance payment. “Sharing with family and friends the gift you gave me, took the focus off my troubles, and I was grateful, an emotion that tends to get buried under the burden of illness. I can only imagine the joy you experience by helping others in their emotional and physical distress – what a beautiful and satisfying profession. You R-O-C-K!” UBCF is proud to support clients like Kathleen during difficult times in their lives.

About UBCF: UBCF, a GuideStar 2022 Platinum Seal of Transparency rated charity as well as a 3-star rated charity with Charity Navigator, is proud to be a source of transparency and a trusted charity for over 20 years. UBCF is committed to offering breast health and wellness services focused on cancer prevention, screening, treatment and overall wellness. UBCF’s mission is to make a positive difference in the lives of those affected by breast cancer and does so through seven life-supporting patient and family programs available to women, men, and families nation-wide. UBCF never denies services to anyone regardless of age, race, gender, ethnicity, income, or medical insurance coverage. Tax-deductible contributions may be made towards UBCF’s programs. UBCF accepts Donor Advised Funds and vehicle and property donations as well. Combined Federal Campaign #77934. https://www.ubcf.org

Share article on social media or email: